PR Newswire
STOCKHOLM, Jan. 5, 2024
STOCKHOLM, Jan. 5, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB's (publ) (Sobi®) (STO: SOBI) ('Sobi') Chairman of the Board Bo Jesper Hansen resigns, at his own request and with immediate effect, from his position as Chairman of the Board and board member due to health reasons.
Bo Jesper Hansen has been deputy Chairman of the Board of Sobi since the annual general meeting in May 2022 and Chairman of the Board of Sobi since the annual general meeting in May 2023. Annette Clancy assumes with immediate effect the role of Chair of the Board. Annette has been a board member of Sobi since 2014 and has extensive experience from executive positions and board positions in the pharmaceutical industry.
"We regret that Bo Jesper needs to resign, and we thank him for his valuable contributions to Sobi", says Annette Clancy, Sobi's incoming Chair of the Board.
Sobi
Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across Europe, North America, the Middle East, Asia and Australia. In 2022, revenue amounted to SEK 18.8 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com, LinkedIn and YouTube.
Contacts
This information is information that Sobi is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 5 January 2024 at 08:00 CET.
Tobias Cottmann
Investor Relations
Phone +41 79 287 10 51
The following files are available for download:
Sobi's Chairman of the Board resigns due to health reasons |
View original content:https://www.prnewswire.co.uk/news-releases/sobis-chairman-of-the-board-resigns-due-to-health-reasons-302027005.html
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.